SMTL ID : 5i9w.1

Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with ANP

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.36 Å

Oligo State

monomer

Ligands

1 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.1: 13 residues within 4Å: Chain A: I.25, G.26, A.27, G.28, E.29, V.33, A.50, T.98, E.99, Y.100, M.101, A.105, L.152 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:I.25, A:A.27, A:E.29, A:T.98, A:E.99, A:M.101, A:A.105 Water bridges: A:R.149 Salt bridges: A:K.52

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 2 residues within 4Å: Chain A: Y.224, R.241 No protein-ligand interaction detected (PLIP) EDO.3: 5 residues within 4Å: Chain A: H.79, N.154, N.156, V.158, K.160 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.154, A:N.156, A:K.160, A:K.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heinzlmeir, S. et al., Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs. ACS Chem. Biol. (2016)

Release Date

2016-11-09

Peptides

Ephrin type-A receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Ephrin type-A receptor 2

Related Entries With Identical Sequence